Endometriosis

Indication for Triptorelin

Population group: Suitable for women, only adults (18 years old or older)

Treatment of endometriosis.

For this indication, competent medicine agencies globally authorize below treatments:

4.2 mg once every 28 days

Route of admnistration

Intramuscular

Defined daily dose

4.2 - 4.2 mg

Dosage regimen

From 4.2 To 4.2 mg once every 28 day(s)

Detailed description

4.2 mg every 28 days. For the treatment of endometriosis the treatment must be initiated in the first five days of the cycle. The maximum duration of treatment should be 6 months.

11.25 mg once every 3 months

Route of admnistration

Intramuscular

Defined daily dose

11.25 - 11.25 mg

Dosage regimen

From 11.25 To 11.25 mg once every 90 day(s)

Detailed description

11.25 mg should be administered every 3 months. For the treatment of endometriosis the treatment must be initiated in the first five days of the cycle. The maximum duration of treatment should be 6 months.

Active ingredient

Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins.

Read more about Triptorelin

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner